PROM1 and colorectal cancer: Indeed, it has been reported that CD133 expression levels correlate with patients survival in colorectal cancers[1-3,30,31] although available data on the presence of CD133+ cells in human colorectal cancers are not always consistent in term of distribution and percentage of positive cells.